Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Free Cash Flow Generation Index
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Free Cash Flow Generation Index of 0.86x as of September 2025. Free cash flow of CN¥418.93 Million represents 1% of operating cash flow (CN¥486.04 Million). See 600420 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai Shyndec Pharmaceutical Co Ltd Free Cash Flow Generation Index (2004–2025)
Historical FCF Generation Index trend for Shanghai Shyndec Pharmaceutical Co Ltd across 22 annual periods. Explore 600420 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Year-by-year Free Cash Flow Generation Index for Shanghai Shyndec Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600420 market cap overview.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.84x | CN¥1.43 Billion | CN¥1.70 Billion | CN¥263.83 Million | ▼ -6.4% |
| 2024 | 0.90x | CN¥2.04 Billion | CN¥2.26 Billion | CN¥219.77 Million | ▲ +13.9% |
| 2023 | 0.79x | CN¥1.36 Billion | CN¥1.72 Billion | CN¥357.19 Million | ▼ -11.2% |
| 2022 | 0.89x | CN¥2.55 Billion | CN¥2.86 Billion | CN¥307.44 Million | ▲ +29.4% |
| 2021 | 0.69x | CN¥1.16 Billion | CN¥1.68 Billion | CN¥521.44 Million | ▼ -9.0% |
| 2020 | 0.76x | CN¥1.18 Billion | CN¥1.56 Billion | CN¥377.98 Million | ▲ +11.1% |
| 2019 | 0.68x | CN¥866.32 Million | CN¥1.27 Billion | CN¥403.82 Million | ▼ -10.3% |
| 2018 | 0.76x | CN¥1.27 Billion | CN¥1.67 Billion | CN¥399.40 Million | ▼ -18.0% |
| 2017 | 0.93x | CN¥2.15 Billion | CN¥2.31 Billion | CN¥168.44 Million | ▲ +30.2% |
| 2016 | 0.71x | CN¥597.27 Million | CN¥838.58 Million | CN¥241.30 Million | ▲ +2150.6% |
| 2015 | -0.03x | CN¥-7.87 Million | CN¥226.65 Million | CN¥234.52 Million | ▲ +94.8% |
| 2014 | -0.67x | CN¥-172.02 Million | CN¥258.51 Million | CN¥430.53 Million | ▲ +54.8% |
| 2013 | -1.47x | CN¥-305.13 Million | CN¥207.50 Million | CN¥512.62 Million | ▼ -34.1% |
| 2012 | -1.10x | CN¥-212.11 Million | CN¥193.41 Million | CN¥405.52 Million | ▼ -2033.3% |
| 2011 | 0.06x | CN¥7.72 Million | CN¥136.12 Million | CN¥128.40 Million | ▲ +116.0% |
| 2010 | -0.36x | CN¥-40.91 Million | CN¥115.11 Million | CN¥156.02 Million | ▼ -152.4% |
| 2009 | 0.68x | CN¥66.14 Million | CN¥97.43 Million | CN¥31.29 Million | ▼ -11.4% |
| 2008 | 0.77x | CN¥44.49 Million | CN¥58.04 Million | CN¥13.56 Million | ▲ +31.8% |
| 2007 | 0.58x | CN¥47.86 Million | CN¥82.31 Million | CN¥34.45 Million | ▲ +268.9% |
| 2006 | 0.16x | CN¥11.60 Million | CN¥73.60 Million | CN¥62.00 Million | ▲ +166.4% |
| 2005 | -0.24x | CN¥-13.75 Million | CN¥57.90 Million | CN¥71.65 Million | ▼ -429.2% |
| 2004 | 0.07x | CN¥1.23 Million | CN¥17.02 Million | CN¥15.79 Million | — |